Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
Arthritis Rheum. 2005 Apr;52(4):1227-36. doi: 10.1002/art.20967.
Arthritis Rheum. 2005.
PMID: 15818699
Free article.
Clinical Trial.